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Measurement of left ventricular ejection fraction is a
common procedure in cardiology. This is not without
reason. Left ventricular ejection fraction has proven to
be an important predictor of mortality in patients with
heart failure and after myocardial infarction [1, 2]. It is
also frequently used to monitor left ventricular remod-
elling after myocardial infarction and to select patients
for ICD therapy and biventricular pacing [3, 4].
Next to this, measurement of left ventricular ejection
fraction is used to detect cardiac toxicity in cancer
treatment, especially chemotherapy with anthracyclines
and related compounds (doxorubicin, daunorubicin,
idarubicin, epirubicin, anthraquinone mitoxantrone)
and trastuzumab [5, 6]. Therefore determination of left
ventricular ejection fraction has to be correct and
reproducible. Fortunately, several techniques are avail-
able to measure left ventricular ejection fraction:
echocardiography, nuclear imaging, magnetic reso-
nance imaging, CT of the heart and contrast
angiography. Echocardiography is the most commonly
used technique, particularly because it is a cheap and
easy to perform technique, gives no irradiation gives no
patient discomfort and can be used anywhere. In
addition, the technique can be used in settings where
MRI cannot be used and in patient with irregular heart
rhythm, which makes radionuclide angiography inac-
curate. Unfortunately the technique is highly operator
dependent and patient dependent. Left ventricular
function is frequently measured with 2D techniques
with extrapolation to a 3D structure, assuming, that the
four chamber view and two chamber view give a correct
display of this 3D structure. In this setting, visual
assessment may not always be accurate [7, 8]. Intra
observer and inter observer variability improves if
quantitative assessment with the Simpson’s rule is used.
In some patients echocardiography is technically cum-
bersome (Patients with pulmonary disease, women with
large breasts and patients with deformations of the
thorax). Contrast enhancement can improve estimates
of left ventricular ejection fraction significantly in this
setting [9]. Magnetic resonance imaging gives also no
radiation exposure, but is more difficult to perform and
more expensive. Because of the high resolution of the
images, the high endocardial intrinsic contrast, the
absence of foreshortening, the absence of user-depen-
dence, the high reproducibility, the ability to perform
3D images and the moderate to high temporal resolu-
tion, MRI has become the gold standard for the last two
decades [10]. Nuclear imaging, CT of the heart and
contrast angiography give radiation exposure, and are
therefore contraindicated in pregnant women, are
relative expensive and require contrast agents (CT and
contrast angiography) with possible adverse effects.
Radionuclide ventriculography was introduced three
decades ago and soon became an accepted technique for
measurement of left ventricular ejection fraction. This
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with a high degree of reproducibility [11]. The advan-
tage is, that measurements do not rely on geometric
assumptions regarding the shape of the left ventricle and
that the patient’s body habitus does not limit the
technique [12]. The technique is performed by labeling
the patient’s red blood pool with a radioactive tracer
(mostly technetium 99m) and measuring radioactivity
over the chest with a gamma camera, as the radioactive
blood flows through the heart. Gated single photon
emission tomography (SPECT) myocardial perfusion
imaging permits simultaneous assessment of ventricular
perfusion and function. It has been compared with
echocardiography and MRI and was closely correlated
[13]. Left ventricular function with cardiac CT can be
acquired within 10–15 s. The technique is very repro-
ducible, as there is usually very good delineation of the
endocardial border of all myocardial walls [14]. Unfor-
tunately, the technique requires a considerable radiation
exposure.
Are these techniques equal and can they be
exchanged? The current paper of Gimelli et al. [15]
throws some light on this issue. The authors show, that
measurements of left ventricular ejection fraction with
echocardiography, radionuclide imaging and contrast
angiography are closely related to each other. All
imaging methods gave prognostic information about
mortality in this study. Although the relationship
between the three methods was very close, individual
measurements with different techniques could obscure
the real situation. Both echocardiography and gated
SPECT tended to overestimate angiographic measure-
ments at the lowest values of LVEF and underestimated
angiographic measurements at the highest value of
LVEF. Differences between the techniques can be
explained by the difference in image building (3D
acquisition in nuclear techniques and 2D techniques
with echocardiography and contrast angiography). And
the sampling of a large number of heart beats in SPECT
imaging and a limited number of images with echocar-
diography and contrast angiography. Possibly the
negative inotropic effect of contrast give an additional
explanation of these findings. The techniques would be
more exchangeable if only 3D imaging (3D echo, MRI,
CT and SPECT) are used, with data acquisition over
several heart beats.
Selection of a proper technique to detect left
ventricular dysfunction, select patients for ICD or
biventricular pacing and guide chemotherapy depends
on the experience of the imaging lab, the patient
characteristics (COPD or atrial fibrillation) and the
availability of the technique in the hospital. If for one
patient a specific technique has been chosen, this
patient has to be imaged with the same technique
during follow-up to avoid artificial improvement or
deterioration of ventricular function. 3D techniques
are preferred for this.
Some guidelines, could be [12]:
Radionuclide ventriculography, Cine MRI or 2D/3D
echocardiography with quantitative measurement of left
ventricular ejection fraction should be used for serial
measurements of left ventricular ejection fraction or
when critical management decisions depend upon the
actual numeric value of the LVEF, such as when to
place an implantable cardioverter-defibrillator, when to
perform surgery in patients with asymptomatic mitral
regurgitation, or whether chemotherapy is contraindi-
cated in a patient with cancer.
2D echocardiography is the preferred technique for
routine assessment of left ventricular ejection fraction
in patients with coronary disease and valvular heart
disease. One has to realise, that visual assessment may
not always be accurate. If the echocardiographic image
quality is suboptimal, one should switch to radionu-
clide angiography or cine-MRI. Gated SPECT
myocardial perfusion nuclear imaging on the other
hand is preferred for simultaneous assessment of
myocardial perfusion and function in patients with
suspected coronary artery disease.
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